# Design Pharmaceuticals, Inc. — Form D

Design Pharmaceuticals, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-02. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-02-02
- Form: D
- Accession: 0001908215-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 1
- Date of first sale: 2022-01-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-431865

## Issuer

- Name: Design Pharmaceuticals, Inc.
- CIK: 0001908215
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 237 PUTNAM AVENUE, CAMBRIDGE, MA, 02139
- Phone: 617-553-1402

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Olivier Clyti | Director | Cambridge, MA |
| Fred Dom | Director | Cambridge, MA |
| John Hastewell | Director | Cambridge, MA |
| Dirk Loeffert | Director | Cambridge, MA |
| Rob Nicol | Director | Cambridge, MA |
| Dirk Loeffert | Executive Officer | Cambridge, MA |
| Rob Nicol | Executive Officer | Cambridge, MA |

## More

- [CIK 1908215 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1908215&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001908215-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.